Helene Depui Ekdal
Keine laufenden Positionen mehr
Profil
Helene Depui Ekdal worked as a Senior Director at AstraZeneca AB from 1996 to 2019.
She also worked as a Director-Clinical Development at Egetis Therapeutics AB.
Ms. Ekdal graduated from Chalmers University of Technology with a graduate degree and obtained an MBA from Handelshögskolan i Göteborg.
Ehemalige bekannte Positionen von Helene Depui Ekdal
| Unternehmen | Position | Ende |
|---|---|---|
| EGETIS THERAPEUTICS AB | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2023 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 01.01.2019 |
Ausbildung von Helene Depui Ekdal
| Chalmers University of Technology | Graduate Degree |
| Handelshögskolan i Göteborg | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EGETIS THERAPEUTICS AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
